ENSC Ensysce Biosciences, Inc.
$0.45▼ -0.02%
Healthcare
Other
Volume 399.8K
Avg Volume (10D) 335.4K
Key Metrics & Fundamentals
Market Cap
$8.75M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.23 - 2.23
% vs 50 MA
0.25%
% vs 200 MA
2.41%
RSI-14
45.4
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.24
Free Cash Flow
-$1.96M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.56M
COGS
–
Operating Exp
$2.58M
Operating Income
-$2.58M
EBIT
-$2.58M
Pretax Income
-$2.57M
Net Income
-$2.57M
EPS (Diluted)
-0.20
Price & Volume History
Loading chart…
Recent News
Ensysce Biosciences Expands Global Investor and Strategic Outreach at Family Office Summit, Dubai
ACCESS Newswire · Oct 21, 2026 8:00 AM ET
Ensysce Biosciences Phase 2 Protocol for CY200 - A Neuroplastigen for the Treatment of CRPS - Submitted to the UK MHRA
ACCESS Newswire · Sep 24, 2026 8:00 AM ET
Ensysce Biosciences Advances CRPS Program at Painweek 2026, Contributes to FDA Hearing on Psychedelic Drug Regulation
ACCESS Newswire · Sep 15, 2026 9:15 AM ET
Ensysce Biosciences' Professor Richard Langford Selected to Speak at FDA Public Hearing on the Potential Future Therapeutic Use of Psychedelic Drugs
ACCESS Newswire · Sep 14, 2026 8:00 AM ET
Ensysce Biosciences Announces Upcoming Conference and Industry Event Participation
ACCESS Newswire · Sep 2, 2026 8:30 AM ET
Ensysce Biosciences Completes Final Phase of PF614-MPAR-102 Clinical Study
ACCESS Newswire · Aug 31, 2026 8:30 AM ET
Ensysce Biosciences to Showcase "A New Era in Pain Therapeutics" at PAINWeek 2026 Symposium
ACCESS Newswire · Aug 20, 2026 8:00 AM ET
Ensysce Biosciences Insider Bought Shares Worth $444,169, According to a Recent SEC Filing
MT Newswires · Aug 18, 2026 6:11 AM ET
ENSC Sets Itself Up Nicely for Critical Stage
Zacks Small Cap Research · Aug 14, 2026 8:12 AM ET
Ensysce Biosciences Reports Second Quarter 2026 Financial Results and Recent Business Highlights
ACCESS Newswire · Aug 13, 2026 4:15 PM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See ENSC's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.